业界动态MHRA

注册医疗器械以投放市场

UK MHRA · 2026-11-11 15:21

正文 · 中文译文

指南 将医疗器械注册以便投放市场 如何为大不列颠和北爱尔兰市场向MHRA注册您的医疗器械。 来自: 药品和保健产品监管局 发布日期: 2020年12月31日 最后更新: 2026年11月11日 — 查看所有更新 获取有关此页面的电子邮件 打印此页面 目录 大不列颠市场注册 投放市场 投入使用 关于投放市场和投入使用的指南 器械的停用 北爱尔兰市场注册 进口商注册 向MHRA注册器械时所需的信息 正在进行性能评估的IVD 冠状病毒检测器械批准(CTDA)及向MHRA注册 申请在器械在线注册系统(DORS)上注册 费用 审查注册 对您的注册进行变更 某些CE证书已过期/即将过期的医疗器械的注册 某些属于欧盟MDD I类可重复使用手术器械或从I类升级分类的欧盟MDD I类医疗器械的注册 某些CE证书已过期/即将过期的IVD器械的注册 注册欧盟IVDR从通用IVD器械升级分类的IVD器械 制造商公共注册簿 全球医疗器械命名法 参考指南 账户管理参考指南 器械注册参考指南 视频教程 联系方式 所有医疗器械,包括体外诊断器械(IVD)、定制器械以及系统或手术包,在投放大不列颠(英格兰、威尔士和苏格兰)市场之前,必须向MHRA注册。 在大不列颠,器械必须符合《2002年医疗器械条例》(SI 2002 No 618,经修订)(UK MDR 2002)在大不列颠的适用规定,方可投放市场并向MHRA注册。 北爱尔兰的注册要求有所不同。 您必须确保向MHRA注册的所有信息准确且为最新。 您的器械向MHRA(英国主管当局)注册不代表MHRA的任何形式的认可、认证、批准或背书。 因此,您不得作出任何此类的声称,包括在任何营销材料、器械包装、使用说明、实验室标签/单据或任何其他文件中使用任何MHRA标志。 作为我们对医疗器械和产品向MHRA注册申请的数据验证和审查的一部分,我们可能会要求您提供进一步的技术文档,以证明您的产品符合《医疗器械条例》的要求。 大不列颠市场注册 以下要求适用于将您的器械投放大不列颠市场。 UK MDR 2002要求您在将器械投放大不列颠市场之前通知MHRA。 如果您或您的公司销售、租赁、出借或赠送以下产品,则必须进行注册: 您制造的I类、IIa类、IIb类或III类器械 您翻新的或贴有您自己名称标签的I类、IIa类、IIb类或III类器械 任何包含至少一个医疗器械的系统或手术包 定制器械 您制造的体外诊断器械(IVD) 正在进行性能评价的体外诊断器械 如果制造商位于英国境外,则必须指定一名英国责任人来对其所有医疗器械承担责任。 英国责任人随后将承担制造商在向MHRA注册器械方面的责任。 有关英国责任人角色的更多信息,请参阅指南。 如果对注册进行任何变更,每份申请可能需要缴纳法定费用。请参阅我们的费用部分。 请注意,任何前大不列颠授权代表若未在2026年3月30日前将其角色更新为英国责任人,其DORS账户现已关闭。 根据《2002年英国医疗器械法规》(UK MDR 2002),“投放市场”和“投入使用”均为定义术语。在大多数情况下,器械将首先被投放市场,随后在到达最终用户时被投入使用。 投放市场 投放市场是指器械首次在GB市场上可供使用、分销或两者兼有的行为。它适用于免费提供和以付费方式提供的器械。这适用于每种器械的首次供应,而非每种类型或型号的器械。 在将器械投放到GB市场之前,必须向MHRA注册。 投入使用 投入使用是指器械可供最终用户使用的阶段。 在有限的情况下,器械可以在未投放GB市场的情况下投入使用。这种情况可能发生在器械由制造商或最终用户制造和使用、且未进行营销或分销时——例如医院在现场制造并使用自己的医疗器械。 在向MHRA注册器械之前,您应考虑您的器械是投放市场、投入使用,还是两者兼有。如果医疗器械既投入使用又投放市场,则必须向MHRA注册该器械。 如果医疗器械仅投入使用,则鼓励向MHRA注册,但并非强制要求。 关于投放市场和投入使用的指南 阅读我们关于投放市场和投入使用注册要求的指南 器械的停用 制造商可以停止供应医疗器械。根据UK MDR 2002,器械在投放市场之前必须向MHRA注册,且在该器械仍在GB市场上可供使用期间,必须维持该注册。 如果器械停产,且不再有后续产品投放市场,则不再需要向MHRA注册。此规定自该器械不再在英国大不列颠(GB)市场上市之日起适用。对于已在市场上的器械,上市后监督和警戒要求将继续适用。 您必须确保向MHRA注册的所有信息准确且最新。有关如何注销不再投放市场的器械的更多信息,请遵循《器械注册参考指南》中的“管理已注册器械”指南。 北爱尔兰市场注册 当您首次将器械投放北爱尔兰市场时,需要向MHRA注册定制器械。 位于北爱尔兰或欧盟以外的制造商,如果希望将器械投放北爱尔兰市场,需要任命一名位于欧盟或北爱尔兰的授权代表。 大不列颠制造商必须任命一名位于欧盟或北爱尔兰的授权代表,才能将器械投放北爱尔兰市场。如果任命了位于北爱尔兰的授权代表,该授权代表需要向MHRA注册在北爱尔兰市场上提供的定制器械。 自2026年5月28日起,所有医疗器械(定制器械除外)在投放欧盟及北爱尔兰市场前,必须在欧盟医疗器械数据库(EUDAMED)上完成注册。自该日起,不再要求进行MHRA注册。 总部位于英国的制造商若要将器械投放北爱尔兰市场,仍需在欧盟或北爱尔兰设立授权代表。 定制器械无需在EUDAMED上注册。此类器械必须继续按以下规定在MHRA注册。 北爱尔兰注册要求——定制器械 《2021年医疗器械(北爱尔兰议定书)条例》要求所有制造商,无论其地理位置如何,均须在定制器械投放北爱尔兰市场后28天内向MHRA注册。 参见我们关于北爱尔兰“投放市场”定义的指南。 如已指定位于北爱尔兰的授权代表,该授权代表可代表制造商向MHRA注册定制器械。 如已指定位于欧盟的授权代表,制造商必须向MHRA注册其所有定制器械。 尚未拥有器械在线注册系统(DORS)账户的英国制造商必须创建DORS账户并注册其定制器械。只需一个DORS账户即可同时注册大不列颠和北爱尔兰市场。 如果符合以下情况,请通过电子邮件 Device.Registrations@mhra.gov.uk 联系 MHRA,获取关于如何注册您的定制器械的说明: 您是位于英国境外的制造商,且 您没有位于北爱尔兰的授权代表,且 您希望将定制器械投放北爱尔兰市场 进口商的注册 位于大不列颠的进口商必须将其进口器械投放大不列颠市场的意向告知相关制造商或英国责任主体(UK Responsible Person)。 在此情况下,制造商或英国责任主体负责向 MHRA 提交进口商的详细信息,包括进口商在大不列颠的营业场所。 不进口器械投放大不列颠市场的经销商和其他供应商无需在 MHRA 注册。 位于北爱尔兰的进口商必须遵守欧盟医疗器械条例(EU MDR)(2017/745)或欧盟体外诊断医疗器械条例(EU IVDR)(2017/746)中的进口商义务。自 2026 年 5 月 28 日起,北爱尔兰进口商将被要求进行 EUDAMED 注册。 在 MHRA 注册器械时所需的信息 在尝试向 MHRA 注册器械之前,请确保您的器械符合经修订的《2002 年英国医疗器械条例》(UK MDR 2002)第 2 条所载解释中医疗器械或体外诊断医疗器械的定义。 “医疗器械”是指任何仪器、装置、器具、软件、材料或其他物品,无论单独使用还是组合使用,连同任何附件,包括制造商预期专门用于诊断或治疗目的或两者兼有且为其正确应用所必需的软件,其—— (a) 制造商预期用于人类,目的为—— (i) 疾病的诊断、预防、监测、治疗或缓解, (ii) 损伤或残疾的诊断、监测、治疗、缓解或补偿, (iii) 解剖结构或生理过程的研究、替代或改变,或 (iv) 控制生育;且 (b) 其在人体内或人体上实现其主要预期作用的方式不是通过药理学、免疫学或代谢手段,即使其功能由此类手段辅助, 并包括预期用于给药或含有作为整体组成部分的物质(该物质若单独使用将成为药品且可能对机体产生辅助于该器械作用的器械。 “体外诊断医疗器械”是指符合以下条件的医疗器械—— (a) 为试剂、试剂产品、校准品、质控品、试剂盒、仪器、装置、设备或系统,无论单独使用还是组合使用;且 (b) 制造商预期用于体外检查来源于人体的样本,包括血液和组织捐献物,单独或主要以提供以下信息为目的—— (i) 关于生理或病理状态, (ii) 关于先天性异常, (iii) 确定捐献物(包括血液和组织捐献物)与潜在受者的安全性和相容性,或 (iv) 监测治疗措施, 并包括样本容器,但不包括用于一般实验室用途的产品,除非该产品鉴于其特性,被制造商特别预期用于体外诊断检查 如果您不确定您的器械是否符合上述定义,特别是如果您正在进行自我认证符合性声明注册,请参阅临界产品:如何判断您的产品是否为医疗器械 在MHRA注册器械时,您必须提供下列信息。这些清单并非详尽无遗,作为我们审查和数据验证流程的一部分,我们可能会要求您提供进一步的技术文档。 制造商详细信息: 器械标签/包装上显示的法人实体名称和地址 公司类型(例如有限公司、个体经营者) 行政联系人(您最多可设置15名有访问权限的人员) 英国负责人指定函(如适用) 英国 responsible persons(英国负责人)的指定函是一份法律合同,声明您是代表制造商的独家英国负责人,并明确您受约代表制造商必须承担的任务。指定合同中必须包含的强制性任务可在我们的英国负责人监管指南中查阅。 制造商或北爱尔兰授权代表(如已指定)必须为北爱尔兰市场注册提交制造商的书面授权委托。该授权委托必须符合欧盟医疗器械法规(EU MDR)2017/745 和/或欧盟体外诊断医疗器械法规(EU IVDR)2017/746 的要求。 器械详情: 适用哪项法规 您注册的器械类别——如果您不确定分类,尤其是当您以自我认证符合性声明进行注册时,请参阅边缘产品:如何判断您的产品是否属于医疗器械 用于描述您器械的全球医疗器械命名(GMDN)®代码和术语 基本 UDI-DI(如适用) 医疗器械名称(品牌/商品/专有名称) 型号或版本详情 目录/参考编号 UDI-DI(如适用) 英国认证机构(或欧盟公告机构)(如适用) 诸如无菌、含乳胶、MRI兼容等属性 您还需要提供任何符合性评估证书或自我认证符合性声明的副本(如适用)。 如果您不知道您的设备适用哪个 GMDN® 代码,您可以从我们的系统中选择相关术语。您无需成为 GMDN® 机构的成员,即可在我们的在线注册系统(DORS)中查找并选择适当的 GMDN® 术语。 但请注意,GMDN® 是一个全球性系统,并非其所有代码和术语在英国均被视为医疗器械。关于某些产品在英国是否属于医疗器械的进一步指导,请参见临界产品:如何判断您的产品是否为医疗器械。 如需查看所需字段的完整视图,请参阅 制造商与器械与产品与进口商属性(MS Excel 电子表格,40.9 KB)。 定制器械 有关于定制器械的进一步信息。其中包括我们所需信息的示例。 如果您提交的是定制有源植入式器械的注册,请向我们提供使用说明书和器械标签的副本。 根据欧盟医疗器械指令(EU MDD)或欧盟有源植入式医疗器械指令(EU AIMDD)的定制器械不能再投放于大不列颠或北爱尔兰市场。请注意,您可以根据 UK MDR 2002 第 II 部分或第 III 部分(目前与 EU MDD 或 EU AIMDD 要求一致)为仅大不列颠市场注册您的定制器械,并附上适当的定制声明。 对于北爱尔兰的医疗器械,根据《2021年医疗器械(北爱尔兰议定书)条例》,定制器械必须符合欧盟医疗器械条例(EU MDR)2017/745,并在英国药品和保健品管理局(MHRA)注册。 符合欧盟医疗器械指令(EU MDD)或欧盟有源植入性医疗器械指令(EU AIMDD)且在2021年5月26日之前在欧盟成员国投放市场的定制器械,仍可在MHRA注册,但仅限于投放北爱尔兰市场。 系统和手术包 系统和手术包属于上述注册要求的范围。如果贵公司以自己的名义投放市场的系统或手术包,在制造商规定的预期用途和限制范围内,包含带有以下任一标志的器械,则需要进行注册: UKCA CE CE UKNI 如果贵公司以自己的名义对包含带有以下任一标志的器械的系统或手术包进行灭菌后投放市场,则需要进行注册: UKCA CE CE UKNI 这适用于制造商预期在使用前进行灭菌的器械。系统和手术包的制造商必须: 使用GMDN®注册每个系统或手术包 添加至少一个基础产品 上传该GMDN®对应的系统和手术包中可能包含的所有组件的清单。 进行性能评估的体外诊断医疗器械(IVD) 在英国进行性能评估研究的体外诊断医疗器械,必须在研究开始时由制造商、英国授权代表(UKRP)或北爱尔兰授权代表完成注册。 正在进行现有性能评估(2020年12月31日前启动)的体外诊断医疗器械(IVDs),也必须由相关人员进行注册。在英国将器械投放市场用于性能评估研究的非英国制造商,将需要一名英国负责人,以便

正文 · 英文原文

Guidance Register medical devices to place on the market How to register your medical devices with the MHRA for the markets in Great Britain and Northern Ireland. From: Medicines and Healthcare products Regulatory Agency Published: 31 December 2020 Last updated: 11 November 2026 — See all updates Get emails about this page Print this page Contents Registration for the Great Britain Market Placing on the market Putting into service Guidance on placing on the market and putting into service Discontinuation of devices Registration for the Northern Ireland market Registration of importers Information required when registering your devices with the MHRA IVDs undergoing performance evaluation Coronavirus test device approval (CTDA) and registering with MHRA Apply to register on the Device Online Registration System (DORS) Fees Review registration Making changes to your registration Registration of certain medical devices that have expired/expiring CE certificates Registration of certain medical devices which are EU MDD Class I reusable surgical instruments or EU MDD Class I medical devices upclassified from Class I Registration of certain IVD devices that have expired/expiring CE certificates Registering IVD devices which the EU IVDR up-classifies from general IVD device Public register of manufacturers Global Medical Device Nomenclature Reference guides Account Management Reference Guide Device Registration Reference Guide Video tutorials Contact All medical devices, including in vitro diagnostic devices (IVDs), custom-made devices and systems or procedure packs, must be registered with the MHRA before they can be placed on the market in Great Britain (England, Wales and Scotland). In Great Britain devices must conform to the Medical Devices Regulations 2002 (SI 2002 No 618, as amended) (UK MDR 2002) as they apply in Great Britain so that they can be placed on the market and registered with the MHRA. Registration requirements differ for Northern Ireland. You must ensure all information registered with the MHRA is accurate and up to date. Registration of your devices with the MHRA (the UK Competent Authority) does not represent any form of accreditation, certification, approval or endorsement by the MHRA. Therefore, you are not permitted to make any claims to this effect, including the use of any MHRA logos in any marketing materials, on device packaging, in the instructions for use, on laboratory tickets/dockets, or in any other documentation. As part of our data validation and scrutiny of applications to register medical devices and products with the MHRA, we may request further technical documentation from you to demonstrate that your products conform to the requirements of the Medical Device Regulations. Registration for the Great Britain Market The following requirements apply to place your device on the Great Britain market. It is a requirement of the UK MDR 2002 that you inform the MHRA before you place your device on the market in Great Britain. You must register if you or your company sells, leases, lends or gifts: Class I, IIa, IIb or III devices you have manufactured Class I, IIa, IIb or III devices you have refurbished or re-labelled with your own name any system or procedure pack containing at least one medical device custom-made devices IVDs you have manufactured IVDs undergoing performance evaluation If the manufacturer is based outside the UK, they must appoint a single UK Responsible Person to take responsibility for all of their medical devices. The UK Responsible Person will then assume the responsibilities of the manufacturer in terms of registering the device with the MHRA. See guidance for more information about the role of the UK Responsible Person. Where any changes to registrations are made, a statutory fee may apply per application. Please see our Fees section. Please note that the DORS accounts of any former Great Britain-based Authorised Representatives who had not updated their role to UK Responsible Person by 30 March 2026 are now closed. Under the UK MDR 2002, “placing on the market” and “putting into service” are defined terms. In most cases, a device will first be placed on the market and will subsequently be put into service when it reaches the end user. Placing on the market Placing on the market is the first making available of a device for use, distribution or both on the GB market. It applies to devices provided both free of charge and in return for payment. This applies to the first supply of each device, not each type or model of device. Before placing a device on the GB market, it must be registered with the MHRA. Putting into service Putting into service refers to the stage at which a device is made available to the final user. There are limited scenarios where a device may be put into service without being placed on the GB market. This may occur when a device is made and used by the manufacturer, or end user, without marketing or distribution – for example a hospital that makes and uses its own medical devices on site. Before registering devices with the MHRA, you should consider if your device is placed on the market, put into service, or both. If a medical device is put into service and placed on the market, you must register the device with the MHRA. If a medical device is put into service only, MHRA registration is encouraged but not required. Guidance on placing on the market and putting into service Read our guidance on the registration requirements for placing on the market and putting into service Discontinuation of devices Manufacturers may discontinue the supply of a medical device. Under the UK MDR 2002, devices must be registered with the MHRA before they are placed on the market, and this registration must be maintained whilst the device is still made available on the GB market. If a device is discontinued, and no further product is placed on the market, registration with the MHRA is no longer required. This applies from the point at which the device is no longer made available on the GB market. Post market surveillance and vigilance requirements will continue for devices already on the market. You must ensure all information registered with the MHRA is accurate and up to date. Follow the manage registered devices guidance in the Device Registration Reference Guide for further information on how to unregister devices that are no longer placed on the market. Registration for the Northern Ireland market There is a requirement to register custom-made devices with the MHRA when you first place your device on the Northern Ireland market. Manufacturers based outside Northern Ireland or the EU are required to appoint an EU or Northern Ireland based Authorised Representative if they wish to place devices on the Northern Ireland market. Great Britain manufacturers must appoint an Authorised Representative based in the EU or Northern Ireland in order to place a device on the Northern Ireland market. Where a Northern Ireland-based Authorised Representative is appointed, the Authorised Representative needs to register custom-made devices made available on the market in Northern Ireland with the MHRA. Since 28 May 2026, all medical devices (other than custom-made devices) must be registered on the European Database on Medical Devices (EUDAMED) prior to placement on the EU and Northern Ireland markets. From this date, MHRA registration has not been required. Great Britain-based manufacturers continue to require an Authorised Representative based in the EU or Northern Ireland in order to place a device on the Northern Ireland market. Custom-made devices do not need to be registered on EUDAMED. Such devices must continue to be registered with the MHRA as set out below. Registration requirements for Northern Ireland – Custom-made devices The Medical Devices (Northern Ireland Protocol) Regulations 2021 require all manufacturers, regardless of geographical location, to register their custom-made devices with the MHRA within 28 days of being made available on the Northern Ireland market. See our guidance on the definition of making available on the market in Northern Ireland. Where a Northern Ireland-based Authorised Representative has been appointed, the Authorised Representative may register custom-made devices with the MHRA on behalf of the manufacturer. Where an EU-based Authorised Representative has been appointed, the manufacturer must register all its custom-made devices with the MHRA. UK manufacturers who do not already have a Device Online Registration System (DORS) account must create a DORS account and register their custom-made devices. You only need one DORS account to register for both the Great Britain and Northern Ireland markets. Contact the MHRA by emailing Device.Registrations@mhra.gov.uk for instructions on how to register your custom-made devices if: you are a manufacturer based outside the UK, and you do not have a Northern Ireland-based Authorised Representative, and you wish to place custom-made devices on the Northern Ireland market Registration of importers A Great Britain-based importer must inform the relevant manufacturer or UK Responsible Person of their intention to import a device for placement on the Great Britain market. In these circumstances, the manufacturer or UK Responsible Person is responsible for submitting the importer’s details to the MHRA, including the importer’s place of business in Great Britain. Distributors and other suppliers that do not import devices for placement on the Great Britain market are not required to be registered with the MHRA. Northern Ireland-based importers must comply with importer obligations in the EU Medical Devices Regulation (EU MDR) (2017/745) or EU in vitro Diagnostic Medical Devices Regulation (EU IVDR) (2017/746). From 28 May 2026, EUDAMED registration of Northern Ireland importers will be required. Information required when registering your devices with the MHRA Before attempting to register devices with the MHRA, please ensure that your device meets the definition of a medical device or an in vitro diagnostic medical device in accordance with the interpretation set out in Regulation 2 of the UK MDR 2002, as amended. “medical device” means any instrument, apparatus, appliance, software, material or other article, whether used alone or in combination, together with any accessories, including the software intended by its manufacturer to be used specifically for diagnosis or therapeutic purposes or both and necessary for its proper application which— (a) is intended by the manufacturer to be used for human beings for the purpose of- (i) diagnosis, prevention, monitoring, treatment or alleviation of disease, (ii) diagnosis, monitoring, treatment, alleviation of or compensation for an injury or handicap, (iii) investigation, replacement or modification of the anatomy or of a physiological process, or (iv) control of conception; and (b) does not achieve its principal intended action in or on the human body by pharmacological, immunological or metabolic means, even if it is assisted in its function by such means, and includes devices intended to administer a medicinal product or which incorporate as an integral part a substance which, if used separately, would be a medicinal product and which is liable to act upon the body with action ancillary to that of the device. “in vitro diagnostic medical device” means a medical device which— (a) is a reagent, reagent product, calibrator, control material, kit, instrument, apparatus, equipment or system, whether used alone or in combination; and (b) is intended by the manufacturer to be used in vitro for the examination of specimens, including blood and tissue donations, derived from the human body, solely or principally for the purpose of providing information— (i) concerning a physiological or pathological state, (ii) concerning a congenital abnormality, (iii) to determine the safety and compatibility of donations, including blood and tissue donations, with potential recipients, or (iv) to monitor therapeutic measures, and includes a specimen receptacle but not a product for general laboratory use, unless that product, in view of its characteristics, is specifically intended by its manufacturer to be used for in vitro diagnostic examination If you are unsure if your device meets the above definitions, and particularly if you are registering with a self-certification conformity declaration, please see Borderline products: how to tell if your product is a medical device When registering devices with the MHRA, you must provide the information listed below. These lists are non-exhaustive, and we may request further technical documentation from you as part of our scrutiny and data validation process. Manufacturer details: legal entity name and address as it appears on the device labelling/packaging company type (for example, limited company, sole trader) administrative contact (you can have up to 15 people with access) a letter of designation for UK Responsible Persons (where applicable) The letter of designation for UK Responsible Persons is a legal contract, stating that you are the exclusive UK Responsible Person acting for the manufacturer and specifying the mandatory tasks you are contracted to undertake on behalf of the manufacturer. The mandatory tasks that must appear in the designation contract can be found in our regulatory guidance for UK Responsible Persons. A written mandate from the manufacturer must be submitted by the manufacturer or the Northern Ireland Authorised representative (where appointed) for registrations for the Northern Ireland market. The mandate must meet the requirements of the EU MDR 2017/745 and/or EU IVDR 2017/746. Device details: which legislation applies the class of device you are registering - if you are unsure of the classification and particularly if you are registering with a self-certification conformity declaration, see Borderline products: how to tell if your product is a medical device Global Medical Devices Nomenclature (GMDN)® Code and Term to describe your device basic UDI-DI (if applicable) medical device name (brand/trade/proprietary name) model or version detail catalogue/reference number UDI-DI (if applicable) UK Approved Body (or EU Notified Body) where applicable attributes such as sterility, contains latex, MRI compatible You also need to provide a copy of any conformity assessment certificates or self-certification conformity declarations, as applicable. If you do not know which GMDN® Code applies to your device, you will be able to select the relevant Term from our system. You do not need to be a member of the GMDN® Agency to find and select the appropriate GMDN® Terms in our online registration system (DORS). However, please note that GMDN® is a worldwide system and not all of its codes and terms are considered to be medical devices in the UK. For further guidance on whether certain products are medical devices in the UK, see Borderline products: how to tell if your product is a medical device. For a full view of the fields required, refer to the Manufacturer and Device and Product and Importer Attributes (MS Excel Spreadsheet, 40.9 KB). Custom-made devices There is further information about custom-made devices. This includes examples of the information we need. If you are submitting a registration for a custom-made active implantable device, provide us with a copy of the instructions for use and the device labelling. Custom-made devices under the EU Medical Devices Directive (EU MDD) or the EU Active Implantable Medical Devices Directive (EU AIMDD) can no longer be placed on the Great Britain or Northern Ireland market. Note that you can register your custom-made device under UK MDR 2002 Part II or Part III (which is currently consistent with EU MDD or EU AIMDD requirements) for the Great Britain market only, with a suitable accompanying custom-made statement. For medical devices in Northern Ireland, under the Medical Devices (Northern Ireland Protocol) Regulations 2021, custom-made devices must comply with the EU MDR 2017/745 and be registered with the MHRA. Custom-made devices that comply with the EU MDD or EU AIMDD and were placed on the market in an EU member state, prior to 26 May 2021, can still be registered with MHRA for the purposes of placing on the Northern Ireland market only. Systems and procedure packs Systems and procedure packs are covered by the registration requirements set out above. You need to register if your company places on the market a system or procedure pack under your own name, and within the intended purposes and limits specified by the manufacturer, which contains devices bearing any of the following marks: UKCA CE CE UKNI You need to register if your company sterilises, to place on the market under your own name, a system or procedure pack which contains devices bearing any of the following marks: UKCA CE CE UKNI This is applicable to devices that are intended by the manufacturer to be sterilised before use. Manufacturers of systems and procedure packs must: register each system or procedure pack using GMDN® add at least one underlying product upload a list of all the possible components that might be included in the system or procedure packs for that GMDN®. IVDs undergoing performance evaluation IVDs subject to performance evaluation studies in the UK must be registered by the manufacturer, UKRP or Northern Ireland Authorised representative by the time the study commences. IVDs that are subject to existing ongoing performance evaluations (commenced before 31 December 2020) must also be registered by the relevant person. Non-UK manufacturers placing devices on the market for performance evaluation studies in Great Britain will require a UK Responsible Person in orde

English
Register medical devices to place on the market
内容仅供参考,不构成诊疗建议,不能替代执业医师的诊断。

← 返回元界